Evidence map›Paper›PMID 30965568›Full record

ReviewInternational journal of molecular sciences2019

Understanding Platelets in Infectious and Allergic Lung Diseases.

Cristina Gomez-Casado, Alma Villaseñor, Alba Rodriguez-Nogales, Jose Luis Bueno, Domingo Barber, Maria M Escribese

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A method based on plateletpheresis to obtain functional platelet, CD3Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Platelets: a potential role in chronic respiratory diseases?European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  12. Review
  13. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  14. Proteomics: A Tool to Study Platelet Function.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cristina Gomez-CasadoInstitute of Applied Molecular Medicine, Department of Basic Medical Sciences, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain. cristina.gomezcasado@ceu.es.
Alma VillaseñorInstitute of Applied Molecular Medicine, Department of Basic Medical Sciences, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain. alma.villasenor@ceu.es.ORCID 0000-0002-6652-2739
Alba Rodriguez-NogalesResearch Laboratory, Allergy Unit, University Hospital of Malaga-IBIMA, 29010 Malaga, Spain. albarnogales@gmail.com.ORCID 0000-0003-1927-0628
Jose Luis BuenoBlood Transfusion & Non-Transfusional Hemotherapy Unit, University Hospital Puerta de Hierro-Majadahonda, 28220 Madrid, Spain. jolubuca1898@gmail.com.
Domingo BarberInstitute of Applied Molecular Medicine, Department of Basic Medical Sciences, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain. domingo.barberhernandez@ceu.es.
Maria M EscribeseInstitute of Applied Molecular Medicine, Department of Basic Medical Sciences, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain. mariamarta.escribesealonso@ceu.es.ORCID 0000-0001-5057-5150
Universidad San Pablo CEU · ESHospital Universitario Puerta de Hierro Majadahonda · ESInstituto de Investigación Biomédica de Málaga · ES

Funding

Consejería de Educación e Investigación 2016-T2/bmd-1838Instituto de Salud Carlos III PI15/02256Instituto de Salud Carlos III PI16/00249Instituto de Salud Carlos III PI18/01467Instituto de Salud Carlos III RD16/0006/0015Instituto de Salud Carlos III RD16/0006/0018
6 · The paper itself

Abstract

Emerging evidence suggests that platelets, cytoplasmic fragments derived from megakaryocytes, can no longer be considered just as mediators in hemostasis and coagulation processes, but as key modulators of immunity. Platelets have received increasing attention as the emergence of new methodologies has allowed the characterization of their components and functions in the immune continuum. Platelet activation in infectious and allergic lung diseases has been well documented and associated with bacterial infections reproduced in several animal models of pulmonary bacterial infections. Direct interactions between platelets and bacteria have been associated with increased pulmonary platelet accumulation, whereas bacterial-derived toxins have also been reported to modulate platelet function. Recently, platelets have been found extravascular in the lungs of patients with asthma, and in animal models of allergic lung inflammation. Their ability to interact with immune and endothelial cells and secrete immune mediators makes them one attractive target for biomarker identification that will help characterize their contribution to lung diseases. Here, we present an original review of the last advances in the platelet field with a focus on the contribution of platelets to respiratory infections and allergic-mediated diseases.

Indexed as

AnimalsBlood PlateletsCommunicable DiseasesHumansLungLung Diseasesallergic inflammationinfectious diseasemediatorsplatelets

Identifiers

PMID30965568
PMCPMC6480134
OpenAlexW2927565920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.